Individuals with focal onset epilepsy treated with azetukalner experienced sustained monthly seizure reduction and evidence of seizure freedom up to 48 months, according to data presented at the ...

We wanted to share an update regarding the recent Planning Inquiry into our proposal to develop part of our estate in ...

Nicola Swanborough, Head of External Affairs at Epilepsy Society said: “We welcome this much-needed overhaul which prioritises treatment for patients with urgent and complex dental requirements. This ...

NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that it has filed a Premarket Approval Supplement (PMA-S) ...

New research from Colorado State University into the ways neurons regulate chemical balance in the brain could provide ...

As of Wednesday, December 17, Bright Minds Biosciences Inc.’s DRUG share price has dipped by 5.83%, which has investors ...

A team of Berlin-based researchers led by Jana Kroll and Christian Rosenmund has captured the fleeting moment a nerve cell releases its ...

Colin Barkley, Chair of NI Children to Lapland and Days to Remember Trust, added: “This is the biggest day of our year and ...

Ukraine has brought back 12 children and teenagers from temporarily occupied territories, including a boy who had no access ...

Jazz Pharmaceuticals plc today announced that the Company will participate in the following investor events: Zanidatamab HERIZON-GEA-01 Investor Webcast on Friday, January 9, 2026 The ...

The Northern Ireland Children to Lapland and Days to Remember Trust (NICLT) has jetted off to Lapland – with two Causeway ...